Spectral Medical Inc. Announces Closing of Approximately C$8.5 Million Convertible Notes Financing
30 mai 2024 11h00 HE
|
Spectral Medical Inc.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF...
Spectral Medical Announces First Quarter Results and Provides Corporate Update
13 mai 2024 07h30 HE
|
Spectral Medical Inc.
Tigris Trial Enrollment Reaches 106 Patients Bought Deal Financing Expected to Fund Completion of Tigris Trial Enrollment TORONTO, May 13, 2024 (GLOBE NEWSWIRE) -- Spectral...
Spectral Medical Inc. Announces C$8.5 Million Bought Deal Convertible Note Financing
09 mai 2024 14h34 HE
|
Spectral Medical Inc.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF...
Spectral Medical Provides April Tigris Trial Update
06 mai 2024 07h30 HE
|
Spectral Medical Inc.
• 105 patients enrolled • April represents a record breaking month for patient enrollment TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:...
Spectral Medical Provides Tigris Trial Update
10 avr. 2024 07h00 HE
|
Spectral Medical Inc.
101 patients enrolled TORONTO, April 10, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for...
Spectral Medical Chair to Retire From the Board of Directors
02 avr. 2024 08h00 HE
|
Spectral Medical Inc.
TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic...
Spectral Medical Announces Fourth Quarter and Fiscal 2023 Results and Provides Corporate Update
28 mars 2024 16h00 HE
|
Spectral Medical Inc.
TORONTO, March 28, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic...
Spectral Medical Provides February Tigris Trial Update
28 févr. 2024 07h30 HE
|
Spectral Medical Inc.
93 patients enrolledFebruary represents a second record breaking consecutive month for patient enrollment TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the...
Spectral Medical Announces Amendment and Extension of Exclusive Supply and Distribution Agreement With Baxter Healthcare Corporation
21 févr. 2024 16h00 HE
|
Spectral Medical Inc.
TORONTO, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Announces Major Milestone by Reaching Its Interim Enrollment Target of 90 Patients
15 févr. 2024 07h41 HE
|
Spectral Medical Inc.
TORONTO, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...